Technology | Women's Health | November 13, 2017

Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Mobile device accurately detects cervical cancer in real time

Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system

Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system with high definition digital colposcope module

Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system with micro-colposcope module

November 13, 2017 — Biop Medical announced it will present its point-of-care cervical cancer detection technology at MEDICA 2017 in Düsseldorf, Germany, Nov. 13-16.  The company recently started its second round of investment.

The tool advances cervical cancer diagnosis using optic technology that accurately detects cancerous and pre-cancer lesions in real time. Patients receive an immediate diagnosis without the prolonged waiting time and stress associated with common diagnostic methods. The technology generates a map of diseased lesions to help physicians pinpoint exactly where to perform biopsies.

Biop Medical’s system consists of two components which are connected to the main control unit. The high definition Biop digital colposcope module offers a high-resolution digital cervix visualization. When the Biop micro-colposcope module is connected, it is directed by an algorithm to the centre of the cervix and then performs a thorough high-magnification inner scan of the cervix.

Using a sterile and disposable cover, the device is inserted until it is in contact with the cervix and projects a full array of light into the full depth of the cervix. The received refractions and reflections off the cervical tissue by the emitted light indicate where cancerous and pre-cancerous lesions are located. When used together, the scans from both components create a color map to help physicians determine where to perform biopsies.

This data can help track the cancer's advancement, with results automatically uploaded to the cloud. The platform for aggregating the data was developed with the support of IBM during Biop Medical's time at the IBM Alpha Zone Accelerator.

The technology requires a short and simple training, compared to years of experience required to capably perform cervical cancer diagnosis with a colposcope.

For more information: www.biopmedical.com

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Videos | Interventional Radiology | January 11, 2019
Julius Chapiro, M.D., research faculty member and an...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
AI Approach Outperformed Human Experts in Identifying Cervical Precancer
News | Digital Pathology | January 10, 2019
January 10, 2019 — A research team led by investigators from the National Institutes of Health and Global Good has de
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Heart Attack, Stroke Risks Increase Leading Up to Cancer Diagnosis
News | Cardio-oncology | December 21, 2018
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...